The Arab Drug Company (EGX:ADCI)

Market Cap	2.13B
Revenue (ttm)	1.03B
Net Income (ttm)	158.78M
Shares Out	12.00M
EPS (ttm)	13.23
PE Ratio	13.42
Forward PE	n/a
Dividend	4.18 (2.32%)
Ex-Dividend Date	Oct 28, 2024

Volume	43,431
Average Volume	109,670
Open	195.49
Previous Close	195.49
Day's Range	180.00 - 203.85
52-Week Range	42.50 - 208.00
Beta	0.66
RSI	67.39
Earnings Date	Sep 1, 2025

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 1,148
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ADCI

Financial Performance

In 2024, The Arab Drug Company's revenue was 785.52 million, an increase of 23.95% compared to the previous year's 633.73 million. Earnings were 88.35 million, an increase of 24.21%.